Remedium Lifecare Ltd.
REMLIFE.BO
Bombay Stock Exchange0.85
INR
- -
- -
Remedium Lifecare Ltd.
REMLIFE.BO
(Bombay Stock Exchange)
Recent
price
0.85
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Remedium Lifecare Ltd. is a pharmaceutical company that manufactures, trades and sells active pharmaceutical ingredients (APIs), key starting materials (KSMs), chemical reference materials (CRMs) and advanced intermediates to innovator and generic pharmaceutical players in domestic and international markets. The company operates across two main verticals, products and services, with its products business encompassing APIs such as Atorvastatin calcium (amorphous and crystalline forms), Citalopram Hydrochloride, Montelukast sodium, Cetirizine dihydrochloride, Levocetirizine dihydrochloride, Pantoprazole sodium, Ambroxol Hydrochloride, Losartan Potassium, Phenylephrine and Phenylephrine Hydrochloride, Lisinopril Dihydrate, Lisinopril, Domperidone and Pregabalin; and advanced intermediates including Tartaric Acid Salt, Thiophene Tosylate, Couple Amine Hydrochloride, Pantoprazole Sulphide, Chloro Compound, Benzimidazole, Pantoprazole n-Oxide, 4-Chloro Benzhydryl Piperazine (CBP), Cetirizine Base, Levo CBP, 2 PMS, Indole II, Indole III and R-Amide. These products serve key therapeutic segments including lipid lowering agents, antidepressants, anti-asthmatics, anti-histamines, proton pump inhibitors, mucolytics, anti-hypertensives, decongestants, antiemetics and anticonvulsants, targeting pharmaceutical manufacturers, hospitals, pharmacies and clinics globally with a focus on India, international markets and emerging sectors like electric vehicle battery materials. Founded in 1988 and headquartered in Mumbai, India, the company, formerly known as Roxy Exports Limited until its name change in November 2020, maintains manufacturing facilities in Hyderabad and employs a lean team of seven under CEO Adarsh Munjal. Remedium Lifecare lists on the Bombay Stock Exchange under ticker REMLIFE.BO and reports in Indian Rupees with a fiscal year ending March. In recent developments, Remedium Lifecare establishes a wholly-owned subsidiary, REMLIFE GLOBAL PTE LTD, in Singapore (Corporate Entity Number 202439223M) to support a USD 200 million overseas project acquisition and rapid international growth. The company enters a one-year strategic alliance with Wave Capital Limited as lead manager and arranger for high-value global business opportunities, approves a USD 25 million capital raise via instruments including Foreign Currency Convertible Bonds, private placements, rights issues, preferential issues, Follow-on Public Offer, Qualified Institutional Placement, Global Depository Receipts and American Depository Receipts pending shareholder and regulatory approvals, and pursues expansion into the electric vehicle sector through an agreement with Angel Partners Ltd., UK, to acquire advanced lithium carbonate production technology alongside a USD 20-25 million annual supply agreement with Alfa Chemicals and Solvents Ltd., Turkey, commencing in Q1 2025 for technical-grade lithium carbonate to serve lithium-ion battery demand via contract manufacturing in India.